Ya-Ju Chang Selected Research

Ya-Ju Chang Research Topics

6	Neoplasms (Cancer) 01/2020 - 07/2012
5	Fatigue 01/2022 - 01/2011
4	Stroke (Strokes) 07/2022 - 11/2017
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 07/2012
2	Insulin Resistance 01/2021 - 01/2020
2	Overweight 01/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 02/2015 - 02/2013
1	Retinal Degeneration 01/2022
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Bites and Stings (Sting) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Atherosclerosis 01/2021
1	Obesity 01/2021
1	Pain (Aches) 11/2017
1	Shoulder Pain 11/2017
1	Prostatic Neoplasms (Prostate Cancer) 08/2017
1	Ischemia 05/2016
1	Necrosis 05/2016
1	Cicatrix (Scar) 02/2014
1	Gliosis 02/2014
1	Uterine Cervical Dysplasia 09/2013
1	Adenocarcinoma of Lung 02/2013
1	Neoplasm Metastasis (Metastasis) 07/2012
1	Hypotension (Low Blood Pressure) 01/2010
1	Spinal Cord Injuries (Spinal Cord Injury) 08/2007

4	chemotactic factor inactivatorIBA 01/2022 - 01/2011
2	PolyphenolsIBA 12/2021 - 07/2012
2	Insulin (Novolin)FDA Link 01/2021 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2021
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2018
1	Vitamin A (Retinol)FDA LinkGeneric 01/2022
1	Rutin (Rutoside)IBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Butylated Hydroxytoluene (BHT)IBA 12/2019
1	Pain-FreeIBA 11/2017
1	AndrogensIBA 08/2017
1	VA 061 (VA061)IBA 08/2017
1	lupeolIBA 08/2017
1	Streptozocin (Streptozotocin)FDA Link 05/2016
1	Nanoparticle Drug Delivery SystemIBA 02/2015
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 02/2014
1	SiliconesIBA 02/2014
1	ChitosanIBA 02/2014
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2013
1	Silicon Dioxide (Silica)FDA LinkGeneric 10/2013
1	NucleotidesIBA 09/2013
1	ErbB Receptors (EGF Receptor)IBA 02/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2013
1	Tyrosine Kinase InhibitorsIBA 02/2013
1	Gefitinib (Iressa)FDA Link 02/2013
1	Protein Kinases (Protein Kinase)IBA 07/2012
1	Adenosine Monophosphate (AMP)IBA 07/2012
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 07/2012

4	Therapeutics 01/2021 - 02/2015
2	Aftercare (After-Treatment) 07/2022 - 12/2019
2	Activities of Daily Living (ADL) 01/2020 - 12/2019
2	Immunotherapy 01/2020 - 01/2018
1	Mirror Movement Therapy 07/2022
1	Deep Brain Stimulation 01/2018
1	Transcutaneous Electric Nerve Stimulation (TENS) 11/2017
1	Neurological Rehabilitation 01/2017
1	Intradermal Injections 05/2016
1	Drug Therapy (Chemotherapy) 02/2015
1	Photochemotherapy (Photodynamic Therapy) 10/2013
1	CT protocol 06/2011
1	Renal Dialysis (Hemodialysis) 01/2010
1	Continuous Passive Motion Therapy 08/2007